Cairo; Stefano
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cairo; Stefano.The latest application filed is for "ssea4 and st3gal2 as chemotherapeutic drug response biomarkers".
- Cairo; Stefano - Longpont-sur-Orge N/A FR
| Patent | Date |
|---|---|
| Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen Grant 9,347,088 - Buendia , et al. May 24, 2 | 2016-05-24 |
| Ssea4 And St3gal2 As Chemotherapeutic Drug Response Biomarkers App 20150316556 - Hardt; Olaf ; et al. | 2015-11-05 |
| Markers For Cancer Prognosis And Therapy And Methods Of Use App 20130042333 - JUDDE; Jean-Gabriel ; et al. | 2013-02-14 |
| Molecular Signature Of Liver Tumor Grade And Use To Evaluate Prognosis And Therapeutic Regimen App 20120040848 - Buendia; Marie-Annick ; et al. | 2012-02-16 |
| Molecular Signature Of Liver Tumor Grade And Use To Evaluate Prognosis And Therapeutic Regimen App 20110183862 - Buendia; Marie Annick ; et al. | 2011-07-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 